Supplements

Guidelines supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs. Items may contain pharmaceutical promotional information.

RICOCHET study supplement

A national audit of pancreatic enzyme replacement therapy (PERT) prescribing in patients with pancreatic cancer: The RICOCHET study

Commissioned by Viatris

This supplement has been commissioned and funded by Viatris and developed in partnership with Guidelines
NON-2021-4065 February 2022

Final version_Opioid supplement

Appropriate use of opioids for chronic pain in primary care

Commissioned by Grünenthal Ltd

This promotional supplement has been commissioned and funded by Grünenthal and developed in partnership with Guidelines. Information intended for healthcare professionals only.
View PALEXIA® SR tablets (tapentadol hydrochloride) prescribing and adverse event reporting information
M-PLX-UK-10-21-0036 October 2021

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.